N-Hexadecyl-pSar25
N-Hexadecyl-pSar25 is a polysarcosine (pSar) derivative featuring a hexadecyl head group and a 25-mer polysarcosine tail. Sarcosine is an amino acid derivated that is being developed as an alternative to PEG for in vivo applications due to its biodegradability and highly reduced antigenicity. pSar-lipid derivatives such as this may be applied in the development of lipid nanoparticles.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 120468-76-0
- Molecular Weight:10900 (Average)
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biologische Aktivität
-
Chemical Information
- Reinheit & Dokumentation
-
Help & FAQs
Biologische Aktivität
Beschreibung
Chemical Information
-
CAS. Nr. 120468-76-0
-
Molecular Weight 10900 (Average)
-
SMILES
CNCC(N(C)CC(NCCCCCCCCCCCCCCCC)=O)=O.[n]
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Hot Topics
-
All
-
Topics
-
Most Recent
-
Oldest
-
Topics Lipid Nanoparticles: Key Nucleic Acid Delivery Vectors
Lipid nanoparticles (LNPs) are the most clinically advanced non-viral delivery systems for nucleic acid therapeutics and enable the in vivo delivery of mRNA, siRNA, and other genetic cargos.
2026-06-18
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
N-Hexadecyl-pSar25 Related Classifications
HY-172510 Related Classifications
Powered by Bioz